Cargando…
_version_ 1784831262341464064
author Assanto, Giovanni Manfredi
Di Rocco, Alice
Malfona, Francesco
Capriata, Marcello
Del Giudice, Ilaria
Petrucci, Luigi
Girardi, Paola
D'elia, Gianna Maria
Martelli, Maurizio
Gentile, Giuseppe
Micozzi, Alessandra
Pulsoni, Alessandro
author_facet Assanto, Giovanni Manfredi
Di Rocco, Alice
Malfona, Francesco
Capriata, Marcello
Del Giudice, Ilaria
Petrucci, Luigi
Girardi, Paola
D'elia, Gianna Maria
Martelli, Maurizio
Gentile, Giuseppe
Micozzi, Alessandra
Pulsoni, Alessandro
author_sort Assanto, Giovanni Manfredi
collection PubMed
description
format Online
Article
Text
id pubmed-9665302
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96653022022-11-16 Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study Assanto, Giovanni Manfredi Di Rocco, Alice Malfona, Francesco Capriata, Marcello Del Giudice, Ilaria Petrucci, Luigi Girardi, Paola D'elia, Gianna Maria Martelli, Maurizio Gentile, Giuseppe Micozzi, Alessandra Pulsoni, Alessandro Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665302/ http://dx.doi.org/10.1182/blood-2022-164544 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Abstracts
Assanto, Giovanni Manfredi
Di Rocco, Alice
Malfona, Francesco
Capriata, Marcello
Del Giudice, Ilaria
Petrucci, Luigi
Girardi, Paola
D'elia, Gianna Maria
Martelli, Maurizio
Gentile, Giuseppe
Micozzi, Alessandra
Pulsoni, Alessandro
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
title Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
title_full Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
title_fullStr Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
title_full_unstemmed Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
title_short Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
title_sort impact of anti-sars-cov-2 monoclonal antibodies in the management of patients with lymphoma and covid19: a retrospective study
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665302/
http://dx.doi.org/10.1182/blood-2022-164544
work_keys_str_mv AT assantogiovannimanfredi impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy
AT diroccoalice impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy
AT malfonafrancesco impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy
AT capriatamarcello impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy
AT delgiudiceilaria impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy
AT petrucciluigi impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy
AT girardipaola impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy
AT deliagiannamaria impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy
AT martellimaurizio impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy
AT gentilegiuseppe impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy
AT micozzialessandra impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy
AT pulsonialessandro impactofantisarscov2monoclonalantibodiesinthemanagementofpatientswithlymphomaandcovid19aretrospectivestudy